Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience

Peter Nguyen; Philip Vutien; Joseph Hoang; Sam Trinh; An Le; Lee Ann Yasukawa; Susan Weber; Linda Henry; Mindie H Nguyen

doi:10.1136/bmjgast-2017-000181

Article info

PDF

XML

Hepatology

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience

Authors

Peter Nguyen Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA School of Medicine, University of Texas Medical Branch, Galveston, Texas, USA PubMed articles Google scholar articles
Philip Vutien Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA PubMed articles Google scholar articles
Joseph Hoang Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA PubMed articles Google scholar articles
Sam Trinh Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA PubMed articles Google scholar articles
An Le Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA PubMed articles Google scholar articles
Lee Ann Yasukawa Center for Clinical Informatics, Stanford School of Medicine, Palo Alto, California, USA PubMed articles Google scholar articles
Susan Weber Center for Clinical Informatics, Stanford School of Medicine, Palo Alto, California, USA PubMed articles Google scholar articles
Linda Henry Pharmaceutical Outcomes and of Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA PubMed articles Google scholar articles
Mindie H Nguyen Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA PubMed articles Google scholar articles

Correspondence to Dr Mindie H Nguyen; mindiehn{at}stanford.edu

View Full Text

Citation

Nguyen P, Vutien P, Hoang J, et al

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience

BMJ Open Gastroenterology 2017;4:e000181. doi: 10.1136/bmjgast-2017-000181

Publication history

Received October 10, 2017
Revised November 18, 2017
Accepted November 21, 2017
First published December 20, 2017.

Online issue publication

April 30, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password